Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092151800> ?p ?o ?g. }
- W2092151800 endingPage "15" @default.
- W2092151800 startingPage "1" @default.
- W2092151800 abstract "Malignant mesothelioma (MM) is an aggressive tumor of the serosal surfaces with a poor prognosis. Advances in the understanding of tumor biology have led to the development of several targeted treatments, which have been evaluated in clinical trials. This article is a comprehensive review of all clinical trials evaluating the effect of targeted treatments in MM. An extensive literature search was performed in January 2011 using pubmed and medline. No constraints on publication date were applied. Thirty-two trials exploring 17 different targeted agents in MM were found. Treatment in first- and second-line targeted agents induced response rates ranging from 0–14% and 0–16%, respectively. The tyrosine kinase inhibitor sunitinib induced partial response in 10% and stable disease in 66% of MPM patients as second-line treatment. A preliminary analysis of a phase II/III trial suggests that addition of bevacizumab to pemetrexed and cisplatin first-line treatment significantly improves disease control (CR + PR + SD) in the bevacizumab arm (73.5%) compared with treatment with pemetrexed and cisplatin without bevacizumab (43.2%) (P = 0.010). Another phase II trial did not observe any significant clinical benefit of adding of bevacizumab to gemcitabine and cisplatin. Disease stabilization is reported in some patients with several targeted treatments and might be beneficial in subgroups of patients or in combination with classic chemotherapy. None of the hitherto explored targeted treatments can currently be recommended as standard treatment in MM." @default.
- W2092151800 created "2016-06-24" @default.
- W2092151800 creator A5058748910 @default.
- W2092151800 creator A5079045120 @default.
- W2092151800 date "2011-05-07" @default.
- W2092151800 modified "2023-10-03" @default.
- W2092151800 title "Review on clinical trials of targeted treatments in malignant mesothelioma" @default.
- W2092151800 cites W1599846307 @default.
- W2092151800 cites W1966272981 @default.
- W2092151800 cites W1967505269 @default.
- W2092151800 cites W1969400254 @default.
- W2092151800 cites W1975069903 @default.
- W2092151800 cites W1979568379 @default.
- W2092151800 cites W1985990605 @default.
- W2092151800 cites W1989561482 @default.
- W2092151800 cites W1990104009 @default.
- W2092151800 cites W1994065185 @default.
- W2092151800 cites W1995837838 @default.
- W2092151800 cites W2003278673 @default.
- W2092151800 cites W2012492706 @default.
- W2092151800 cites W2014943535 @default.
- W2092151800 cites W2015015957 @default.
- W2092151800 cites W2023302219 @default.
- W2092151800 cites W2038126486 @default.
- W2092151800 cites W2041415161 @default.
- W2092151800 cites W2043673524 @default.
- W2092151800 cites W2044717219 @default.
- W2092151800 cites W2048277025 @default.
- W2092151800 cites W2050658031 @default.
- W2092151800 cites W2055698606 @default.
- W2092151800 cites W2057869668 @default.
- W2092151800 cites W2061650454 @default.
- W2092151800 cites W2065144267 @default.
- W2092151800 cites W2065162646 @default.
- W2092151800 cites W2067583075 @default.
- W2092151800 cites W2067837009 @default.
- W2092151800 cites W2068244585 @default.
- W2092151800 cites W2074669585 @default.
- W2092151800 cites W2081508876 @default.
- W2092151800 cites W2086670444 @default.
- W2092151800 cites W2088400491 @default.
- W2092151800 cites W2100576484 @default.
- W2092151800 cites W2100785570 @default.
- W2092151800 cites W2101107286 @default.
- W2092151800 cites W2102627969 @default.
- W2092151800 cites W2104743043 @default.
- W2092151800 cites W2107676690 @default.
- W2092151800 cites W2113954569 @default.
- W2092151800 cites W2114440767 @default.
- W2092151800 cites W2120220319 @default.
- W2092151800 cites W2126237794 @default.
- W2092151800 cites W2126275851 @default.
- W2092151800 cites W2132157071 @default.
- W2092151800 cites W2134123784 @default.
- W2092151800 cites W2135619784 @default.
- W2092151800 cites W2136032785 @default.
- W2092151800 cites W2137131274 @default.
- W2092151800 cites W2137758263 @default.
- W2092151800 cites W2140201170 @default.
- W2092151800 cites W2144660856 @default.
- W2092151800 cites W2144720607 @default.
- W2092151800 cites W2145835533 @default.
- W2092151800 cites W2147394591 @default.
- W2092151800 cites W2151527507 @default.
- W2092151800 cites W2151827208 @default.
- W2092151800 cites W2152529513 @default.
- W2092151800 cites W2154056804 @default.
- W2092151800 cites W2157769714 @default.
- W2092151800 cites W2159811154 @default.
- W2092151800 cites W2160367792 @default.
- W2092151800 cites W2162561140 @default.
- W2092151800 cites W2164208231 @default.
- W2092151800 cites W2169409181 @default.
- W2092151800 cites W2170832030 @default.
- W2092151800 cites W2171299592 @default.
- W2092151800 cites W2283214005 @default.
- W2092151800 cites W2589690880 @default.
- W2092151800 cites W2589957652 @default.
- W2092151800 cites W4211075966 @default.
- W2092151800 cites W4250882992 @default.
- W2092151800 cites W4253646374 @default.
- W2092151800 cites W51995314 @default.
- W2092151800 doi "https://doi.org/10.1007/s00280-011-1655-3" @default.
- W2092151800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21553148" @default.
- W2092151800 hasPublicationYear "2011" @default.
- W2092151800 type Work @default.
- W2092151800 sameAs 2092151800 @default.
- W2092151800 citedByCount "43" @default.
- W2092151800 countsByYear W20921518002012 @default.
- W2092151800 countsByYear W20921518002013 @default.
- W2092151800 countsByYear W20921518002014 @default.
- W2092151800 countsByYear W20921518002015 @default.
- W2092151800 countsByYear W20921518002016 @default.
- W2092151800 countsByYear W20921518002017 @default.
- W2092151800 countsByYear W20921518002018 @default.
- W2092151800 countsByYear W20921518002019 @default.
- W2092151800 countsByYear W20921518002020 @default.
- W2092151800 countsByYear W20921518002022 @default.